PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Apr-2025 Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers Tessellate Bio
23-Apr-2025 Landmark BioVentures and G.CLIPS Biotech forge strategic alliance to address critical gaps in drug target engagement Andrew Lloyd Associates
23-Apr-2025 Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG MetrioPharm
23-Apr-2025 Biosensors Market Size to Grow at 8% CAGR by 2030, Driven by Wearables, AI, and Point-of-Care Diagnostics Medi-Tech Insights
23-Apr-2025 Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange Everest Medicines Limited
22-Apr-2025 AACR 2025: Meteor Biotech showcases CosmoSort, new class of spatial cell sorter enabling deeper translational cancer research Andrew Lloyd Associates
22-Apr-2025 Carthera reaches recruitment milestone in SONOBIRD pivotal trial for recurrent glioblastoma Andrew Lloyd Associates
22-Apr-2025 Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogeneic product, in spine fusion Andrew Lloyd Associates
21-Apr-2025 Biopharmaceutical Process Analytical Technology Market Size Set for Strong Growth at ~16% CAGR by 2030 Medi-Tech Insights
17-Apr-2025 Four new members elected to the Board of Directors of MetrioPharm AG MetrioPharm
15-Apr-2025 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025 Genmab
15-Apr-2025 Peninsula Pathology Network partners with Exponential-e to drive digital pathology transformation Exponential-e
15-Apr-2025 Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 Galapagos
15-Apr-2025 PLL Therapeutics enrolls first patient in phase I/II trial of drug candidate PLL001 for Amyotrophic Lateral Sclerosis (ALS) Andrew Lloyd Associates
15-Apr-2025 Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA HighTide Therapeutics, Inc.
15-Apr-2025 1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research 1ST Biotherapeutics
14-Apr-2025 New GDP Training with Certificate Pharma Lessons
14-Apr-2025 First Patient Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Haemophilia B in Austria CSL Behring
14-Apr-2025 Alfa Chemistry Expands into Marine Chemistry: A Dive into Marine Extracts, Oils, and Natural Products Alfa Chemistry
14-Apr-2025 SMART researchers develop novel UV and machine learning-aided method to detect microbial contamination in cell cultures Blue Totem Communications